Rahnama Ruyan, Mohraz Minoo, Mirzazadeh Ali, Rutherford George, McFarland Willi, Akbari Gholamreza, Malekinejad Mohsen
Global Health Sciences, University of California, San Francisco, USA.
Iranian Research Center for HIV and AIDS, Tehran University of Medical Sciences, Tehran, Iran.
Int J Drug Policy. 2014 Jul;25(4):717-23. doi: 10.1016/j.drugpo.2014.05.013. Epub 2014 Jun 2.
Over the past two decades, drug injection-related risk behaviors have been the major drivers of the HIV epidemic in Iran. This study assesses the access of people who injected drugs (PWID) to harm reduction services (needle-exchange programs [NEP] and methadone maintenance treatment [MMT]) in Tehran, Iran in 2007, almost five years after the large-scale implementation of these programs.
572 consenting PWID (>18 years old, ever injected in the past month, lived in Tehran or its suburbs) were recruited (24 seeds) into a sero-behavioral survey using respondent-driven sampling method. Participants completed a face-to-face interview about HIV-related risk behaviors and access to harm reduction services. We calculated adjusted population estimates using RDSAT.
Overall, 99.2% of the participants were male, 41.6% aged between 30 and 39 years old, 55.4% lived alone in the past year, 83.2% were ever incarcerated, and 88.8% lived in the southern areas of Tehran. In terms of "awareness" and "use" of services among PWID, 62.8% and 54.8% reported for NEP (respectively) and 19.7% and 9.1% for drug treatment services (respectively). PWID who lived in Northwest and South-central Tehran were more likely to be aware (85.0% and 82.8%, respectively) of one or more services than PWID who lived elsewhere. Similarly, PWID who lived with friends were more likely to be aware of (88.6%) and use (85.9%) services (vs. other living partners). Overall, 11% of the participants were aware of but had not used any harm reduction services.
Despite a relatively high level of access to NEP among PWID in Tehran, a sizable fraction of the population remains without access to other services five years after their implementation. The use of harm reduction may be affected by certain PWID characteristics (e.g., living partners and geographical location). Ongoing surveillance activities are necessary to track change in access over time.
在过去二十年中,与药物注射相关的风险行为一直是伊朗艾滋病流行的主要驱动因素。本研究评估了2007年伊朗德黑兰注射吸毒者(PWID)获得减少伤害服务(针头交换项目[NEP]和美沙酮维持治疗[MMT])的情况,此时这些项目已大规模实施近五年。
采用应答驱动抽样方法,招募了572名同意参与的注射吸毒者(年龄>18岁,过去一个月内曾注射过毒品,居住在德黑兰或其郊区)(24名种子)参与血清行为调查。参与者完成了关于艾滋病相关风险行为和获得减少伤害服务情况的面对面访谈。我们使用RDSAT计算了调整后的总体估计数。
总体而言,99.2%的参与者为男性,41.6%年龄在30至39岁之间,55.4%在过去一年独自生活,83.2%曾被监禁,88.8%居住在德黑兰南部地区。在注射吸毒者对服务的“知晓”和“使用”方面,分别有62.8%和54.8%的人报告知晓针头交换项目,19.7%和9.1%的人报告知晓药物治疗服务。居住在德黑兰西北部和中南部的注射吸毒者比居住在其他地方的注射吸毒者更有可能知晓一种或多种服务(分别为85.0%和82.8%)。同样,与朋友一起生活的注射吸毒者更有可能知晓(88.6%)并使用(85.9%)服务(与其他生活伴侣相比)。总体而言,11%的参与者知晓但未使用任何减少伤害服务。
尽管德黑兰的注射吸毒者获得针头交换项目的比例相对较高,但在项目实施五年后,仍有相当一部分人群无法获得其他服务。减少伤害服务的使用可能受到某些注射吸毒者特征(如生活伴侣和地理位置)的影响。持续的监测活动对于跟踪随时间推移获得服务情况的变化是必要的。